T. Rowe Price Associates’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320K | Buy |
10,460
+1,521
| +17% | +$46.5K | ﹤0.01% | 2504 |
|
|
2025
Q1 | $242K | Buy |
8,939
+1,705
| +24% | +$46.2K | ﹤0.01% | 2554 |
|
|
2024
Q4 | $260K | Buy |
7,234
+985
| +16% | +$35.4K | ﹤0.01% | 2564 |
|
|
2024
Q3 | $237K | Buy |
6,249
+41
| +0.7% | +$1.56K | ﹤0.01% | 2582 |
|
|
2024
Q2 | $281K | Buy |
6,208
+359
| +6% | +$16.3K | ﹤0.01% | 2449 |
|
|
2024
Q1 | $284K | Buy |
5,849
+494
| +9% | +$24K | ﹤0.01% | 2458 |
|
|
2023
Q4 | $288K | Buy |
5,355
+667
| +14% | +$35.9K | ﹤0.01% | 2389 |
|
|
2023
Q3 | $275K | Buy |
4,688
+332
| +8% | +$19.5K | ﹤0.01% | 2364 |
|
|
2023
Q2 | $275K | Buy |
4,356
+122
| +3% | +$7.7K | ﹤0.01% | 2401 |
|
|
2023
Q1 | $267K | Sell |
4,234
-1,073
| -20% | -$67.7K | ﹤0.01% | 2401 |
|
|
2022
Q4 | $282K | Buy |
5,307
+205
| +4% | +$10.9K | ﹤0.01% | 2395 |
|
|
2022
Q3 | $286K | Buy |
5,102
+674
| +15% | +$37.8K | ﹤0.01% | 2403 |
|
|
2022
Q2 | $320K | Buy |
4,428
+771
| +21% | +$55.7K | ﹤0.01% | 2409 |
|
|
2022
Q1 | $291K | Buy |
3,657
+526
| +17% | +$41.9K | ﹤0.01% | 2551 |
|
|
2021
Q4 | $317K | Sell |
3,131
-650
| -17% | -$65.8K | ﹤0.01% | 2576 |
|
|
2021
Q3 | $349K | Buy |
3,781
+20
| +0.5% | +$1.85K | ﹤0.01% | 2519 |
|
|
2021
Q2 | $385K | Sell |
3,761
-727
| -16% | -$74.4K | ﹤0.01% | 2490 |
|
|
2021
Q1 | $438K | Sell |
4,488
-109
| -2% | -$10.6K | ﹤0.01% | 2428 |
|
|
2020
Q4 | $354K | Buy |
+4,597
| New | +$354K | ﹤0.01% | 2369 |
|